by admin | Sep 26, 2019 | Funding
AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins a phase I trial of its first-in-class Alzheimer’s disease drug. This is the first milestone payment in a deal worth up to €1.6B (CHF 1.7B), which Eli Lilly and AC Immune signed to develop...
by admin | Sep 25, 2019 | Funding
HTG Molecular Diagnostics Announces Completion of $22.5 Million Aggregate Financing, Consisting of $19.0 Million Public Offering of Common Stock, Including the Exercise in Full of the Underwriter’s Option to Purchase Additional Shares, and $3.5 Million Concurrent...
by admin | Sep 25, 2019 | Funding
Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announced that it has successfully secured €7 million in seed funding. The funding round involves a syndicate of leading...
by admin | Sep 25, 2019 | Funding
Sexton Biotechnologies announced that it has raised $5 million in growth capital and is the first company incubated by Indianapolis-based Cook Regentec to secure outside investment capital and spin out as an independent biotechnology company. In addition to ongoing...
by admin | Sep 16, 2019 | Funding
Incredible Health, based in San Francisco, has worked with customers like Stanford Healthcare, UCSF Medical Center, Cedars Sinai Medical Center and many others to fill their nursing staffing needs. Incredible Health raised $15 million in Series A funding led by...
by admin | Sep 15, 2019 | Funding
San Jose-based BrightInsight is a spin-off from contract manufacturer Flex and has raised funding for its internet-of-things platform for connected medical devices and drug delivery systems. Investors recently poured $25 million into BrightInsight that is looking to...
